Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES | 10 | - | +29,60 % | ||
| AVADEL PHARMACEUTICALS | 9 | 6 | -1,63 % | ||
| VANDA PHARMACEUTICALS | 4 | - | +6,70 % | ||
| AMNEAL PHARMACEUTICALS | 4 | - | 0,00 % | ||
| BIONTECH | 3 | 13 | +0,18 % | ||
| DENALI THERAPEUTICS | 3 | - | -0,06 % | ||
| ROYALTY PHARMA | 3 | - | +0,62 % | ||
| BIOGEN | 2 | 54 | +0,10 % | ||
| AMGEN | 2 | 27 | -3,46 % | ||
| BIOMEA FUSION | 2 | 6 | +2,92 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21:06 | $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today | 3 | Benzinga.com | ||
| 20:01 | Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? | 2 | The Motley Fool | ||
| 19:42 | Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? | 8 | Benzinga.com | ||
| 16:42 | Trium Capital discloses 1.16% stake in Avadel Pharmaceuticals | 1 | Investing.com | ||
| 16:34 | Trium Kapital meldet Beteiligung von 1,16 % an Avadel Pharmaceuticals | 2 | Investing.com Deutsch | ||
| 16:30 | Erste Group upgrades Amgen stock rating to Buy from Hold on obesity drug | 10 | Investing.com | ||
| 16:30 | EILMELDUNG: Biontech-Aktie auffällig ruhig - steht der Ausbruch kurz bevor? | Hebelschein-Spekulant | |||
| 16:22 | Citadel legt 1,2 %-Anteil an Avadel Pharmaceuticals offen | 1 | Investing.com Deutsch | ||
| 16:22 | Erste Group stuft Amgen-Aktie wegen Adipositas-Medikament auf 'Kaufen' hoch | 12 | Investing.com Deutsch | ||
| 16:18 | Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals | 1 | Investing.com | ||
| 16:10 | Merck's Keytruda SC launch in Germany faces new hurdle as Halozyme scores preliminary injunction | 6 | FiercePharma | ||
| 16:10 | ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study | 1 | Zacks | ||
| 16:06 | Insider Transaction: August J Troendle Sells $394K Worth Of Medpace Holdings Shares | 1 | Benzinga.com | ||
| 16:02 | Is Tempus AI the Next Big Artificial Intelligence Stock to Buy? | 12 | The Motley Fool | ||
| 15:58 | Janus Henderson meldet 3,84 %-Beteiligung an Avadel Pharmaceuticals | 1 | Investing.com Deutsch | ||
| 15:42 | Stoke, Biogen Present Positive Long-Term Results For Zorevunersen In Dravet Syndrome | 212 | AFX News | WESTON (dpa-AFX) - Stoke Therapeutics, Inc. (STOK) and Biogen Inc. (BIIB) on Friday reported positive long-term data from the Phase 1/2a and open-label extension studies evaluating zorevunersen... ► Artikel lesen | |
| 15:30 | Jazz Pharmaceuticals to present new Epidiolex data at epilepsy meeting | 3 | Investing.com | ||
| 15:30 | Amylyx's ALS drug AMX0114 shows positive early safety data | 1 | Investing.com | ||
| 15:10 | Biogen Inc.: Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting | 227 | GlobeNewswire (Europe) | -Long-term Phase 1/2a and open label extension (OLE) data for zorevunersen on top of standard of care anti-seizure medicines (ASMs)
demonstrate durable seizure reductions, including increases in... ► Artikel lesen | |
| 15:10 | Denali Enters Into a $275M Funding Deal With Royalty Pharma | 1 | Zacks |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .